Search

everythinglearnresearchcommunity

for

Search:↓

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

Hair loss in children is often caused by scalp infections, immune disorders, hair pulling, stress, and requires careful treatment due to emotional effects.

The document concludes that available medical treatments for common hair loss disorders are generally safe and effective, and the emotional impact of hair loss should be considered in treatment plans.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Non-drug methods like diet, supplements, and aromatherapy can help manage hair loss and its emotional impact.

Hair loss is common after bariatric surgery, especially vertical sleeve gastrectomy, and is linked to emotional distress.

Hormonal imbalances can cause acne, excess hair growth, and hair loss in women, needing combined medical and emotional care.

Most children in orphanages in Fayoum and Giza have skin disorders, mainly noninfectious, and need better hygiene and emotional care.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Early treatment of children's hair loss, which can be caused by various factors, is important due to its emotional impact.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Minoxidil and Propecia are the only FDA-approved hair growth drugs, but concerns about side effects lead people to explore herbal alternatives.

Herbal medicines can be effective alternatives for treating hair loss.

Minoxidil and Propecia are the only FDA-approved hair growth drugs, but people are exploring herbal alternatives due to concerns about side effects.

Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

The review suggests seeing a dermatologist for scarring hair loss and using treatments like minoxidil or finasteride for common male and female pattern hair loss.

Substance P may contribute to hair loss by increasing oxidative stress and mitochondrial activity in hair follicles.

Androgenetic alopecia causes hair loss, and early, ongoing treatment is key for best results.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.